A 27-year-old woman with well-controlled bipolar disorder on lithium requests the drospirenone POP. Is there a specific concern?...

Question

A 27-year-old woman with well-controlled bipolar disorder on lithium requests the drospirenone POP. Is there a specific concern?

Accepted Answer

Drospirenone has potassium-sparing properties; lithium toxicity can be potentiated by electrolyte disturbances. U&E monitoring and caution are advised

Answer

No specific concern

Answer

Lithium is an enzyme inducer

Answer

The drospirenone POP treats bipolar disorder

Answer

Lithium increases the efficacy of the POP

uk-dfsrh MCQ (SBA): Drospirenone POP with Lithium

A 27-year-old woman with well-controlled bipolar disorder on lithium requests the drospirenone POP. Is there a specific concern?